CNRS Nantes University US2B US2B
home |  start a new run |  job status |  references&downloads |  examples |  help  

Should you encounter any unexpected behaviour,
please let us know.
 elNémo has been hacked on november 27th.
It has been moved away and runs again.
**Still some additional cleaning from time to time**
Sorry for the inconvenience.


***  IMMUNE SYSTEM 14-NOV-18 6N2U  ***

<R2> analysis for 2604131021151763097

---  normal mode 90  ---

This page gives a visualization of the normalized mean square displacement <R2> of all C-alpha atoms in the protein that are associated to this mode (black bars). The three components of the corresponding eigenvector are shown on the left (colored bars). Here is the raw data for <R2> and for the eigenvector (shift-click on the links for download).

XYZresidue<R2><R2>max = 0.0623
LYS 10.0054
GLU 20.0124
LEU 30.0291
ARG 40.0556
CYS 50.0192
GLN 60.0233
CYS 70.0623
ILE 80.0096
LYS 90.0367
THR 100.0187
TYR 110.0087
SER 120.0312
LYS 130.0401
PRO 140.0080
PHE 150.0196
HIS 160.0306
PRO 170.0153
LYS 180.0236
PHE 190.0182
ILE 200.0043
LYS 210.0175
GLU 220.0211
LEU 230.0243
ARG 240.0193
VAL 250.0230
ILE 260.0186
GLU 270.0278
SER 280.0242
GLY 290.0279
PRO 300.0294
HIS 310.0178
CYS 320.0078
ALA 330.0407
ASN 340.0316
THR 350.0191
GLU 360.0167
ILE 370.0141
ILE 380.0192
VAL 390.0152
LYS 400.0162
LEU 410.0107
SER 420.0234
ASP 430.0278
GLY 440.0257
ARG 450.0368
GLU 460.0164
LEU 470.0093
CYS 480.0140
LEU 490.0143
ASP 500.0110
PRO 510.0133
LYS 520.0186
GLU 530.0201
ASN 540.0077
TRP 550.0044
VAL 560.0076
GLN 570.0080
ARG 580.0114
VAL 590.0089
VAL 600.0031
GLU 610.0082
LYS 620.0146
PHE 630.0070
LEU 640.0120
LYS 650.0149
ARG 660.0150
ALA 670.0319
GLU 680.0104
ASN 690.0265

If you find results from this site helpful for your research, please cite one of our papers:

elNémo is maintained by Yves-Henri Sanejouand.
It was developed by Karsten Suhre.
Between 2003 and 2014, it was hosted by IGS (Marseille).
Between 2015 and 2025, it was hosted by US2B (Nantes).
Last modification: december 26th, 2025.